mibefradil has been researched along with 1-naphthylamine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chubanov, V; Ferioli, S; Gudermann, T; Hofmann, T; Schäfer, S; Zierler, S | 1 |
1 other study(ies) available for mibefradil and 1-naphthylamine
| Article | Year |
|---|---|
Mibefradil represents a new class of benzimidazole TRPM7 channel agonists.
Topics: 1-Naphthylamine; Animals; Calcium; Calcium Channel Blockers; HEK293 Cells; Humans; Magnesium; Mibefradil; Mice; Naltrexone; TRPM Cation Channels | 2016 |